DEC 06, 2019 11:30 AM PST

Federal Restrictions Make It Hard For Cannabis Researchers

WRITTEN BY: C Reardon

With marijuana use becoming more popular in aiding health, scientists race to find clarity around its health benefits and risks. Since the legalization of medical marijuana, available science has been lacking. Providers are unable to counsel patience in this area with the proper science backing. 

In the United States, over 22 million people are consuming cannabis products without the scientific understanding around what the potential risks or benefits may be. Currently, legislatures are still identifying what health conditions can legally be aided by medical marijuana, but often without dependable evidence.

This is concerning considering that cannabis-related emergency room visits have increased, and the cannabis market is projected to triple in the next five years. We must grow our understanding of this drug as quickly as possible.

What stands in the way of solid scientific research? The tight federal restrictions around cannabis research in the United States. To date, researchers are limited to just a few varieties of cannabis compounds, which is certainly not a reflection of the wide range available to consumers. Under federal law, marijuana is classified as a Schedule I controlled substance, which means it is considered to have low medicinal value, with high addictive qualities. The Drug Enforcement Administration (DEA) believes that there is not enough evidence to change its classification. Still, under this classification, it is hard for researchers to do thorough research due to restrictions.

Photo Source: Pixabay.com

Researchers can be fined or face criminal penalties if they do not follow the strict guidelines and rules set in place by the DEA in regards to cannabis research. 

The Association of American Medical Colleges says that a change in classification from a Substance I to a Substance III would be beneficial for cannabis research. They also suggested that the DEA allow for the expansion of growers, as well as the number of varieties that they produce for research. They say that these varieties “need to be varieties that can be inhaled, ingested, or applied to the skin.”

About the Author
  • Chelsey is a content strategist and copywriter with a business degree. She has a background in public relations and marketing and enjoys writing about various topics, from health, to lifestyle, to women’s issues. Since 2016, she has written for a variety of online publications, earning well over 100,000 shares. She published her first book in 2019.
You May Also Like
OCT 07, 2020
Cancer
Delivering Cancer Drugs to Osteosarcoma with Nanoparticles
OCT 07, 2020
Delivering Cancer Drugs to Osteosarcoma with Nanoparticles
Over the years, cancer researchers have struggled not just with drug and diagnostic design, but with drug delivery. The ...
OCT 05, 2020
Cell & Molecular Biology
Gaining Insight Into the Connection Between Depression and Stress
OCT 05, 2020
Gaining Insight Into the Connection Between Depression and Stress
Depression is a common mental illness, and stress is known to be an environmental influence that can increase the risk o ...
OCT 09, 2020
Cannabis Sciences
Older Adults Use Cannabis for Common Health Problems
OCT 09, 2020
Older Adults Use Cannabis for Common Health Problems
Researchers from the University of California San Diego have found that older adults tend to use cannabis for medical pu ...
OCT 13, 2020
Immunology
Why Halloween Is Extra Scary for Kids With Peanut Allergies
OCT 13, 2020
Why Halloween Is Extra Scary for Kids With Peanut Allergies
A recent study showed that there is an 85 percent spike in peanut allergy anaphylaxis cases on Halloween. The study, per ...
OCT 15, 2020
Health & Medicine
An Estimated 38 Million People were Exposed to Polluted Wildfire Smoke
OCT 15, 2020
An Estimated 38 Million People were Exposed to Polluted Wildfire Smoke
As wildfires continue to burn record-breaking acreages along the west coast of the United States and inland regions, hos ...
OCT 26, 2020
Cancer
Investigating the Receptor Protein FPR1 in Brain Cancer
OCT 26, 2020
Investigating the Receptor Protein FPR1 in Brain Cancer
Amongst the more common targets for cancer therapies are cell surface receptors. These receptors are proteins – us ...
Loading Comments...